Breast Cancer, Version 3.2024

被引：156

作者：

Gradishar, William J. ^{[1
]}

Moran, Meena S. ^{[2
]}

Abraham, Jame ^{[3
,4
]}

Abramson, Vandana ^{[5
]}

Aft, Rebecca ^{[6
,7
]}

Agnese, Doreen ^{[8
,9
]}

Allison, Kimberly H. ^{[10
]}

Anderson, Bethany ^{[11
]}

Bailey, Janet ^{[12
]}

Burstein, Harold J. ^{[13
]}

Chen, Nan ^{[14
]}

Chew, Helen ^{[15
]}

Dang, Chau ^{[16
]}

Elias, Anthony D. ^{[17
]}

Giordano, Sharon H. ^{[18
]}

Goetz, Matthew P. ^{[19
]}

Jankowitz, Rachel C. ^{[20
]}

Javid, Sara H. ^{[21
]}

Krishnamurthy, Jairam ^{[22
]}

Leitch, A. Marilyn ^{[23
]}

Lyons, Janice ^{[3
,4
]}

McCloskey, Susie ^{[24
]}

Mcshane, Melissa ^{[25
]}

Mortimer, Joanne ^{[26
]}

Patel, Sameer A. ^{[25
]}

Rosenberger, Laura H. ^{[27
]}

Rugo, Hope S. ^{[28
]}

Santa-Maria, Cesar ^{[29
]}

Schneider, Bryan P. ^{[30
]}

Smith, Mary Lou ^{[31
]}

Soliman, Hatem ^{[32
]}

Stringer-Reasor, Erica M. ^{[33
]}

Telli, Melinda L. ^{[10
]}

Wei, Mei ^{[34
]}

Wisinski, Kari B. ^{[11
]}

Yeung, Kay T. ^{[35
]}

Young, Jessica S. ^{[36
]}

Schonfeld, Ryan ^{[37
]}

Kumar, Rashmi ^{[37
]}

机构：

[1] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[2] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[3] Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Cleveland, OH USA

[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH USA

[5] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[6] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[7] Washington Univ, Sch Med, St Louis, MO USA

[8] Ohio State Univ, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA

[9] Solove Res Inst, Columbus, OH USA

[10] Stanford Canc Inst, Stanford, CA USA

[11] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[12] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[13] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[14] UChicago, Med Comprehens Canc Ctr, Chicago, IL USA

[15] Univ Calif Davis, Comprehens Canc Ctr, Davis, CA USA

[16] Mem Sloan Kettering Canc Ctr, New York, NY USA

[17] Univ Colorado, Canc Ctr, Boulder, CO USA

[18] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[19] Mayo Clin, Comprehens Canc Ctr, Rochester, MN USA

[20] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[21] Fred Hutchinson Canc Ctr, Seattle, WA USA

[22] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[23] UT Southwestern, Simmons Comprehens Canc Ctr, Dallas, TX USA

[24] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[25] Fox Chase Canc Ctr, Philadelphia, PA USA

[26] City Hope Natl Med Ctr, Duarte, CA USA

[27] Duke Canc Inst, Durham, NC USA

[28] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[29] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MA USA

[30] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA

[31] Res Advocacy Network, Plano, TX USA

[32] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[33] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[34] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[35] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA USA

[36] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[37] Natl Comprehens Canc Network, Cleveland, OH USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 05期

关键词：

GROWTH-FACTOR RECEPTOR; ADJUVANT ENDOCRINE THERAPY; 21-GENE RECURRENCE SCORE; TRIAL COMPARING DOXORUBICIN; PATIENT-LEVEL METAANALYSIS; EPIRUBICIN PLUS DOCETAXEL; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY; 7-YEAR FOLLOW-UP; QUALITY-OF-LIFE;

D O I：

10.6004/jnccn.2024.0035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Breast cancer is treated with a multidisciplinary approach involving surgical oncology, radiation oncology, and medical oncology. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Breast Cancer include recommendations for clinical management of patients with carcinoma in situ, invasive breast cancer, Paget's disease, Phyllodes tumor, inflammatory breast cancer, and management of breast cancer during pregnancy. The content featured in this issue focuses on the recommendations for overall management of systemic therapy (preoperative and adjuvant) options for nonmetastatic breast cancer. For the full version of the NCCN Guidelines for Breast Cancer, visit NCCN.org.

引用

页码：331 / 357

页数：27

共 180 条

[11] Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen-To Offer More? (aTTom) trial [J].

Bartlett, J. M. S. ;

Sgroi, D. C. ;

Treuner, K. ;

Zhang, Y. ;

Ahmed, I ;

Piper, T. ;

Salunga, R. ;

Brachtel, E. F. ;

Pirrie, S. J. ;

Schnabel, C. A. ;

Rea, D. W. .

ANNALS OF ONCOLOGY, 2019, 30 (11) :1776-1783

[12]

Baum M, 2002, LANCET, V359, P2131

[13] Pharmacokinetics of anastrozole and tamoxifen alone, and in combination, during adjuvant endocrine therapy for early breast cancer in postmenopausal women:: a sub-protocol of the 'Arimidex™ and Tamoxifen Alone or in Combination' (ATAC) trial [J].

Baum, M ;

Dowsett, M ;

Coibion, M ;

Bianco, AR ;

Cuzick, J ;

George, WD ;

Gray, J ;

Howell, A ;

Houghton, J ;

Williams, N ;

Sloane, J ;

Tobias, J ;

Buzdar, A ;

Anderson, MD ;

Jackson, I ;

Sahmoud, T ;

Gallagher, J ;

Webster, A ;

Gangji, D ;

Petrakova, K ;

Konopasek, B ;

Mares, P ;

Vodvarka, P ;

Alcazar, A ;

Campos, O ;

Maxwell, A ;

Goedhals ;

Hacking, D ;

Landers, G ;

Smith, L ;

Vorobiof, DA ;

Werner, ID ;

Blamey, R ;

Coleman, R ;

Grieve, RJ ;

Hickish, T ;

Howell, A ;

Nicholls, JC ;

Nicholson, S ;

Raymond, S ;

Salman, A ;

Blum, J ;

Clark, R ;

Lyss, A ;

Miletello, G ;

Sternberg, J ;

Forbes, J ;

Coibion, M ;

Nabholtz, JM ;

Guastalla, JP .

BRITISH JOURNAL OF CANCER, 2001, 85 (03) :317-324

[14]

Bergh J, 2021, LANCET ONCOL, V22, P1139, DOI 10.1016/S1470-2045(21)00288-6

[15] Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer [J].

Berry, DA ;

Cirrincione, C ;

Henderson, IC ;

Citron, ML ;

Budman, DR ;

Goldstein, LJ ;

Martino, S ;

Perez, EA ;

Muss, HB ;

Norton, L ;

Hudis, C ;

Winer, EP .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (14) :1658-1667

[16] HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer [J].

Berry, DA ;

Muss, HB ;

Thor, AD ;

Dressler, L ;

Liu, ET ;

Broadwater, G ;

Budman, DR ;

Henderson, IC ;

Barcos, M ;

Hayes, D ;

Norton, L .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (20) :3471-3479

[17] Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) [J].

Blok, Erik J. ;

Kroep, Judith R. ;

Kranenbarg, Elma Meershoek-Klein ;

Duijm-de Carpentier, Marjolijn ;

Putter, Hein ;

van den Bosch, Joan ;

Maartense, Eduard ;

van Leeuwen-Stok, A. Elise ;

Liefers, Gerrit-Jan ;

Nortier, Johan W. R. ;

Rutgers, Emiel J. Th. ;

van de Velde, Cornelis J. H. .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2018, 110 (01) :40-48

[18] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial [J].

Boccardo, F. ;

Rubagotti, A. ;

Guglielmini, P. ;

Fini, A. ;

Paladini, G. ;

Mesiti, M. ;

Rinaldini, M. ;

Scali, S. ;

Porpiglia, M. ;

Benedetto, C. ;

Restuccia, N. ;

Buzzi, F. ;

Franchi, R. ;

Massidda, B. ;

Distante, V. ;

Amadori, D. ;

Sismondi, P. .

ANNALS OF ONCOLOGY, 2006, 17 :VII10-VII14

[19] Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole trial [J].

Boccardo, F ;

Rubagotti, A ;

Puntoni, M ;

Guglielmini, P ;

Amoroso, D ;

Fini, A ;

Paladini, G ;

Mesiti, M ;

Romeo, D ;

Rinaldini, M ;

Scali, S ;

Porpiglia, M ;

Benedetto, C ;

Restuccia, N ;

Buzzi, F ;

Franchi, R ;

Massidda, B ;

Distante, V ;

Amadori, D ;

Sismondi, P .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5138-5147

[20] Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials [J].

Boddington, C. ;

Bradley, R. ;

Braybrooke, J. ;

Burrett, J. ;

Clarke, M. ;

Davies, C. ;

Davies, L. ;

Dodwell, D. ;

Duane, F. ;

Evans, V. ;

Gettins, L. ;

Godwin, J. ;

Gray, R. ;

Hills, R. ;

James, S. ;

Liu, H. ;

Liu, Z. ;

MacKinnon, E. ;

Mannu, G. ;

McGale, P. ;

McHugh, T. ;

Morris, P. ;

Pan, H. ;

Peto, R. ;

Read, S. ;

Taylor, C. ;

Wang, Y. ;

Wang, Z. ;

Bradley, R. ;

Braybrooke, J. ;

Gray, R. ;

Bergh, J. ;

Peto, R. ;

Gray, Richard ;

Bradley, Rosie ;

Braybrooke, Jeremy ;

Liu, Zulian ;

Peto, Richard ;

Davies, Lucy ;

Dodwell, David ;

McGale, Paul ;

Pan, Hongchao ;

Taylor, Carolyn ;

Barlow, William ;

Bliss, Judith ;

Bruzzi, Paolo ;

Cameron, David ;

Fountzilas, George ;

Loibl, Sibylle ;

Mackey, John .

LANCET, 2019, 393 (10179) :1440-1452

← 1 2 3 4 5 6 7 8 9 10 →